Clariant’s stock fell sharply on Wednesday after the Swiss chemicals major announced its nine-month CEO Ernesto Occhiello had resigned for personal reasons with immediate effect.
Clariant’s shares were down more than 4% on the Swiss stock exchange by 10:15 CET.
Current chairman and former CEO Hariolf Kottmann has taken over in the interim. CFO Patrick Jany remains at his post.
Occhiello was appointed CEO of Clariant in September 2018, after the Saudi petrochemicals major took over a 24.99% stake at the company in January that year.
The move followed two dramatic years at the Swiss producer after a failed merger with US major Huntsman and activist pressure for the board to change course.
SABIC finally took over the activist investors’ stake, paying around Swiss francs (Swfr) 2bn ($2bn) for the 24.99% stake.
A spokesperson for Clariant said to ICIS that employees had been “surprised” at Ochiello’s resignation after only nine months in the post, adding that a search for an “internal or external” replacement was underway.
“The board accepted his resignation and asked Kottmann to take over his responsibilities in his role of executive chairman,” said the spokesperson.
KOTTMAN, OCCHIELLO AT ODDS
Some chemicals equity analysts have said Occhiello’s sudden resignation may be related to disagreements between Kottmann and the newly appointed CEO, forecasting further pain for the company’s stock given the “insecurity” it creates for the company.
Germany’s investment bank Baader Bank’s chemicals analysts linked the resignation of board member Christian Kohlpaintner in June as part of the proof that Occhiello (pictured) had not been able to establish a new management team of his liking.
“Christian Kohlpaintner was put in place by Hariolf Kottmann when he came on board,” said Baader’s Markus Mayer.
“[Reasons for Occhiello to leave could include] 1) He and the former CEO had conflicts on how to run/transform Clariant; 2) SABIC changed its strategy on the integration process of the High Performance Materials business and Ernesto Occhiello would have been conflicted (as former SABIC manager). 3) SABIC changed its investment strategy on its Clariant asset (i.e. not to just have 25% but to fully take over) and Ernesto Occhiello would have been conflicted,” added Mayer.
“No matter what the reason(s) for Occhiello resignation is, it creates insecurity and another moving part in the Clariant investment story and therefore should weigh on the share price.”
SABIC had not responded to a request for comment at the time of writing.
Clariant is due to release its second-quarter results on 25 July.
Source: ICIS News
Corteva (Indianapolis, Indiana) says it has signed a definitive agreement to acquire Stoller Group (Houston, Texas), a producer of biostimulants and plant nutrition products, for $1.2 billion. Stoller is one of the largest independent biologicals companies globally, with operations in more than 60 countries and more than $400 million in annual sales.
OMV has announced its new corporate structure today, designed to fully enable the delivery of Strategy 2030. The new organization will be built on five distinct areas. In addition to the CEO and CFO areas, three business segments will be established: Chemicals & Materials, Fuels & Feedstock, and Energy.
The European petchem sector is readying for some tough quarters. It’s a different picture in the US. So is this the best time ever to find a new role in the chemical industry? If you are in Europe, you would expect me to say probably not. But actually, it depends. So let me give you four answers to this question.